Kulkarni, Jayashri http://orcid.org/0000-0002-3875-5623
Thomas, Natalie
Hudaib, Abdul-Rahman
Gavrilidis, Emorfia
Grigg, Jasmin
Tan, Raelene
Cheng, Jacinta
Arnold, Amelia
Gurvich, Caroline
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial
https://doi.org/10.1007/s40263-018-0506-8
Funding for this research was provided by:
Private Philanthropic Grant provided by Dr Jeff Wolinksi
National Health and Medical Research Council (1129815)
Article History
First Online: 16 March 2018
Compliance with Ethical Standards
:
: The authors (Jayashri Kulkarni, Natalie Thomas, Abdul- Rahman Hudaib, Emorfia Gavrilidis, Jasmin Grigg, Raelene Tan, Jacinta Cheng, Amelia Arnold and Caroline Gurvich) have no conflicts of interest to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: National Health and Medical and Research Council (NHMRC) Project Grant: 1129815 and Private Philanthropic Grant provided by Dr. Jeff Wolinski, C/o Monash University Fundraising Department, Faculty of Medicine, Nursing and Health Sciences.
: Written informed consent was obtained from all individual participants included in the study.